Haemonetics (HAE) Tops Q1 EPS by 9c

Haemonetics (NYSE: HAE) reported Q1 EPS of $1.10, $0.09 better than the analyst estimate of $1.01. Revenue for the quarter came in at $321.39 million versus the consensus estimate of $302.62 million.

For earnings history and earnings-related data on Haemonetics (HAE) click here.

You May Also Be Interested In

• Tesla readies August launch of CyberCab - The Information
• Micron Technology (MU) call put ratio 1.4 calls to 1 put on 1.2M contracts as share price up 4%
• Market Vectors Semiconductor ETF (SMH) call put ratio 1 call to 1.7 puts as share price up 1%